Skip to content

Effect of High Omega-3 Fish Intake on Lipid Peroxidation

Effect of High Omega-3 Fish Intake on Lipid Peroxidation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01183520
Enrollment
30
Registered
2010-08-17
Start date
2010-09-30
Completion date
2012-12-31
Last updated
2022-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipid Peroxidation, Omega-3 Fatty Acids

Brief summary

The overall goal of this project is to identify an appropriate level of high omega-3 fish (salmon) consumption that will promote optimal omega 3 nutritional status without increasing the level of lipid oxidation in the body.

Detailed description

Studies have demonstrated that the intakes of fatty fish and fish oils are associated with decreases in cardiovascular disease and other chronic disease states. This is related to the long chain omega-3 fatty acid (n-3) content of fish and fish oil, specifically eicosapentaenoic acid and docosahexaenoic acid. Although the consumption of high n-3 fish is recommended in the 2005 US Dietary Guidelines for Americans, no specific consumption levels are made for the fatty acid eicosapentaenoic acid (EPA) and/or the fatty acid docosahexaenoic acid (DHA) or total fish intake. Consumption of high n-3 fish or dietary supplementation of fish oil will lead to increased levels of these fatty acids in plasma lipoproteins, cell and tissue lipid. This change in membrane lipid is thought to be responsible for the anti-inflammatory effects of n-3. Because highly unsaturated fatty acid are subject to peroxidation, the level of fish intake that is sufficient to modify membrane n-3 content and the exact level that enhances peroxidation is unknown. We will perform a dose-response feeling study in which varied levels of fish (salmon) will be provided in random order separated by 4 or more week washout periods. We will assess the level of cell membrane enrichment with n-3 and the effect on lipid peroxidation outcomes.

Interventions

DIETARY_SUPPLEMENTOmega-3 fish oil provided by salmon

Eating 3 different amounts of provided salmon twice a week for four weeks

Sponsors

United States Department of Agriculture (USDA)
CollaboratorFED
University of North Dakota
CollaboratorOTHER
USDA Grand Forks Human Nutrition Research Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 25-34.9 * Non-smoker * Free of major medical conditions * Willing to comply with protocol requirements

Exclusion criteria

* Use of lipid modifying drugs or supplements * Taking fish oil or flax supplements * Regular fish consumer * Planning to gain to lose weight * Pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Long chain omega-3 fatty acid (n-3)6 monthsEffect of different levels of n-3 intake on n-3 fatty acids in plasma lipoproteins, cell and tissue lipids (cell enrichment)

Secondary

MeasureTime frameDescription
lipid peroxidation6 monthsEffect of different levels of n-3 intake on lipid peroxidation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026